The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2Susanne Krasemann, Ole Pleß, Fabian Heinrich et al.|Stem Cell Reports|2022Cited by 239
Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous manFrancisco Lopera, Yakeel T. Quiroz, Claudia Mariño et al.|Nature Medicine|2023Cited by 191